All Stories

  1. Diaphragmatic CMAP amplitude from phrenic nerve stimulation predicts functional decline in ALS
  2. Hypothesis: amyotrophic lateral sclerosis and environmental pollutants
  3. Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis
  4. Immobility and F‐waves: Impact on lower motor neuron excitability
  5. Chitinases, neuroinflammation and biomarkers in ALS
  6. Cervical muscle weakness is a marker of respiratory dysfunction in amyotrophic lateral sclerosis
  7. Testing electrolyte supplementation for muscle cramp
  8. Face-making: task-specific facial tensions and grimacing in musicians
  9. Clinical trials in the ALS syndrome: it is time for change
  10. Professor Henry Urich 1916–2015: A London neuropathologist and his Polish heritage
  11. Vascular endothelial growth factor and amyotrophic lateral sclerosis: The interplay with exercise and noninvasive ventilation
  12. Sensitivity of MUP parameters in detecting change in early ALS
  13. Origin of Fasciculations in Amyotrophic Lateral Sclerosis and Benign Fasciculation Syndrome
  14. Does surgery accelerate progression of amyotrophic lateral sclerosis?
  15. Controversies and priorities in amyotrophic lateral sclerosis
  16. Fasciculation potentials and earliest changes in motor unit physiology in ALS
  17. Awaji Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis
  18. Motor unit firing in amyotrophic lateral sclerosis and other upper and lower motor neurone disorders
  19. How does ALS spread between neurones in the CNS?
  20. Primary lateral sclerosis: Predicting functional outcome
  21. Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis?: Figure 1
  22. Fasciculation potentials: Still mysterious
  23. Patrikios syndrome in two patients with treatable flail-leg weakness
  24. Respiratory exercise in amyotrophic lateral sclerosis
  25. Love lies bleeding--those who are left behind salute you
  26. Amyotrophic lateral sclerosis
  27. Muscle ultrasound detects fasciculations and facilitates diagnosis in ALS
  28. Survey of non-invasive ventilation use in ALS in Britain
  29. The Awaji criteria for diagnosis of ALS
  30. Nitric oxide and muscle weakness
  31. Does the motor cortex influence denervation in ALS? EMG studies of muscles with both contralateral and bilateral corticospinal innervation
  32. Meetings at the RSM
  33. Sacrocolpopexy may cause difficult defecation by inhibiting the external opening out mechanism
  34. The onset of ALS?
  35. Fasciculation-cramp syndrome preceding anterior horn cell disease: an intermediate syndrome?
  36. Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis
  37. Internet facilitated management improves home ventilation in amyotrophic lateral sclerosis
  38. Coping with motor neuron disease: how do people adapt to the devastating reality?
  39. Lithium time-to-event trial in amyotrophic lateral sclerosis stops early for futility
  40. CSF markers in amyotrophic lateral sclerosis: Has the time come?
  41. Association of paraspinal and diaphragm denervation in ALS
  42. Apraxia contributes to the motor deficit in Parkinson’s Disease and Multiple System Atrophy
  43. Peer review and ‘openness’
  44. What Is Really New in Progressive Muscle Atrophy?
  45. An error of self-diagnosis--but what was the real diagnosis?
  46. Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis
  47. Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene
  48. Predicting respiratory insufficiency in amyotrophic lateral sclerosis: The role of phrenic nerve studies
  49. Money and medicine: A problem that won't go away
  50. Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: A six-month longitudinal study
  51. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis
  52. Motor unit changes in thoracic paraspinal muscles in amyotrophic lateral sclerosis
  53. Paraspinal and limb motor neuron involvement within homologous spinal segments in ALS
  54. The innervation of muscle and the neuron theory
  55. Electrodiagnostic criteria for diagnosis of ALS
  56. Learning from failed trials in ALS
  57. Monomelic neurogenic syndromes: A prospective study
  58. LIMB-KINETIC APRAXIA IN PARKINSON DISEASE
  59. And Lord Brain said ...
  60. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies
  61. The phagocytic capacity of neurones
  62. Homozygous mutation inMYH7in myosin storage myopathy and cardiomyopathy
  63. Multifocal motor neuropathy: Is conduction block essential?
  64. Hughlings Jackson's clinical research: Evidence from contemporary documents
  65. Rectal Hyposensitivity
  66. Can Selection of Rapidly Progressing Patients Shorten Clinical Trials in Amyotrophic Lateral Sclerosis?
  67. What's in a name?: Lumping or splitting ALS, PLS, PMA, and the other motor neuron diseases
  68. European ALS Consortium (EALSC): Second annual Research Workshop, a summary report
  69. John Hughlings Jackson (1835–1911)
  70. Quantitating progression in ALS
  71. Neurophysiological measures in amyotrophic lateral sclerosis: Markers of progression in clinical trials
  72. New ideas for therapy in ALS
  73. Clinical trials in ALS: A review of the role of clinical and neurophysiological measurements
  74. The stem cell problem: Expectations and reality
  75. The Neurophysiological Index in ALS
  76. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial
  77. Analysis of force profile during a maximum voluntary isometric contraction task
  78. Sarcoid polyneuropathy responsive to intravenous immunoglobulin
  79. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis
  80. Motor responses evoked by transcranial magnetic stimulation and peripheral nerve stimulation in the ulnar innervation in amyotrophic lateral sclerosis: the effect of upper and lower motor neuron lesion
  81. Measures of Quality of Life: Summary
  82. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions
  83. Controversies about databases
  84. F-Waves and the corticospinal lesion in amyotrophic lateral sclerosis
  85. Ethical standards for authors, and for the Journal of Amyotrophic Lateral Sclerosis and other motor neuron diseases
  86. What does the neurologist expect from clinical neurophysiology?